<html>
<head>PUBMED IDs for DACT3</head>
<body bgcolor='#C5F0F2'><h1>DACT3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18538736/'>DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.</a> June 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21642358/'>Common genetic variants related to genomic integrity and risk of papillary thyroid cancer.</a> October 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21642356/'>Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21931769/'>Suppression of breast tumor growth and metastasis by an engineered transcription factor.</a> June 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21931765/'>MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.</a> June 9  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22144423/'>ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.</a> June 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/28108314/'>MiRNA-638 promotes autophagy and malignant phenotypes of cancer cells via directly suppressing DACT3.</a> January 22  2017<br></body></html>
